Surgery Partners revises 2025 outlook to $3.275B-$3.3B revenue amid capital deployment delays and volume softness (NASDAQ:SGRY)
Group 1 - The article does not provide any relevant content regarding company or industry insights [1]
Group 1 - The article does not provide any relevant content regarding company or industry insights [1]